482
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

An in silico approach to identify potential medicinal plants for treating Alzheimer disease: a case study with acetylcholinesterase

ORCID Icon, , , , , ORCID Icon, ORCID Icon & show all
Pages 1521-1533 | Received 21 Jun 2020, Accepted 21 Sep 2020, Published online: 06 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Samson O. Famuyiwa, Rajesh B. Patil, Kolade O. Faloye, Iyanu O. Awotuya, Sandeep P. Gadhawe, Oluyemi J. Oladiran & Oyenike I. Bello. (2023) Sappanin-type homoisoflavonoids from Scilla nervosa inhibits acetylcholinesterase enzyme: a combined in silico and in vitro approach. Journal of Biomolecular Structure and Dynamics 41:20, pages 10957-10968.
Read now

Articles from other publishers (3)

Sindhya Malkaje, Mahendra Gowdru Srinivasa, Shridhar Deshpande N, Suharsha Navada & Revanasiddappa BC. (2023) An In-silico Approach: Design, Homology Modeling, Molecular Docking, MM/GBSA Simulations, and ADMET Screening of Novel 1,3,4-oxadiazoles as PLK1inhibitors. Current Drug Research Reviews 15:1, pages 88-100.
Crossref
James H. Zothantluanga, Abd. Kakhar Umar, H. Lalhlenmawia, Sathishkumar Vinayagam, Malita Sarma Borthakur, Lima Patowary & Dubom Tayeng. 2023. Phytochemistry, Computational Tools and Databases in Drug Discovery. Phytochemistry, Computational Tools and Databases in Drug Discovery 257 283 .
Smitha Sunil Kumaran Nair, Rajamohamed Beema Shafreen, Saqar Said Nasser Al Maskari, Nallusamy Sivakumar, Kiran Gopakumar Rajalekshmi & Adhraa Al Mawaali. (2022) An In-silico Approach to Identify Potential Drug Molecules for Alzheimer’s Disease: A Case Involving Four Therapeutic Targets. Letters in Drug Design & Discovery 19:6, pages 541-548.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.